IGFBP1 Antibodies

Santa Cruz Biotechnology features a diverse variety of IGFBP1 monoclonal antibodies for research focused on understanding Insulin-like Growth Factor Binding Protein 1. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).IGFBP1 plays a crucial role in regulating the availability and activity of insulin-like growth factors, which are essential for cell growth, development, and metabolism. By binding to insulin-like growth factors, IGFBP1 modulates their interaction with receptors, influencing cellular signaling pathways. Understanding IGFBP1 function is vital for elucidating implications in various physiological and pathological processes, including growth disorders and metabolic diseases. Research has shown IGFBP1 involvement in glucose homeostasis and insulin sensitivity. IGFBP1 expression patterns vary across different tissues and respond to metabolic changes. Recent studies have highlighted IGFBP1's potential as a biomarker for metabolic conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of IGFBP1's role in human health and disease.